Slominsky PA - Search Results

1

Potential Biomarkers of the Earliest Clinical Stages of Parkinson's Disease.

Alieva AKh, Filatova EV, Karabanov AV, Illarioshkin SN, Slominsky PA, Shadrina MI. Alieva AKh, et al. Among authors: slominsky pa. Parkinsons Dis. 2015;2015:294396. doi: 10.1155/2015/294396. Epub 2015 Sep 21. Parkinsons Dis. 2015. PMID: 26483988 Free PMC article.

2

Association study of sporadic Parkinson's disease genetic risk factors in patients from Russia by APEX technology.

Shadrina M, Nikopensius T, Slominsky P, Illarioshkin S, Bagyeva G, Markova E, Ivanova-Smolenskaia I, Kurg A, Limborska S, Metspalu A. Shadrina M, et al. Neurosci Lett. 2006 Sep 25;405(3):212-6. doi: 10.1016/j.neulet.2006.06.066. Epub 2006 Jul 28. Neurosci Lett. 2006. PMID: 16876316

3

Effective quantitative real-time polymerase chain reaction analysis of the parkin gene (PARK2) exon 1-12 dosage.

Shadrina MI, Semenova EV, Slominsky PA, Bagyeva GH, Illarioshkin SN, Ivanova-Smolenskaia II, Limborska SA. Shadrina MI, et al. Among authors: slominsky pa. BMC Med Genet. 2007 Feb 26;8:6. doi: 10.1186/1471-2350-8-6. BMC Med Genet. 2007. PMID: 17324265 Free PMC article.

4

Comparison of the temporary dynamics of NGF and BDNF gene expression in rat hippocampus, frontal cortex, and retina under Semax action.

Shadrina M, Kolomin T, Agapova T, Agniullin Y, Shram S, Slominsky P, Lymborska S, Myasoedov N. Shadrina M, et al. J Mol Neurosci. 2010 May;41(1):30-5. doi: 10.1007/s12031-009-9270-z. Epub 2009 Aug 7. J Mol Neurosci. 2010. PMID: 19662538

5

Expression of inflammation-related genes in mouse spleen under tuftsin analog Selank.

Kolomin T, Shadrina M, Andreeva L, Slominsky P, Limborska S, Myasoedov N. Kolomin T, et al. Regul Pept. 2011 Oct 10;170(1-3):18-23. doi: 10.1016/j.regpep.2011.05.001. Epub 2011 May 24. Regul Pept. 2011. PMID: 21609736

6

The temporary dynamics of inflammation-related genes expression under tuftsin analog Selank action.

Kolomin T, Morozova M, Volkova A, Shadrina M, Andreeva L, Slominsky P, Limborska S, Myasoedov N. Kolomin T, et al. Mol Immunol. 2014 Mar;58(1):50-5. doi: 10.1016/j.molimm.2013.11.002. Epub 2013 Nov 27. Mol Immunol. 2014. PMID: 24291245

7

Involvement of endocytosis and alternative splicing in the formation of the pathological process in the early stages of Parkinson's disease.

Alieva AKh, Shadrina MI, Filatova EV, Karabanov AV, Illarioshkin SN, Limborska SA, Slominsky PA. Alieva AKh, et al. Among authors: slominsky pa. Biomed Res Int. 2014;2014:718732. doi: 10.1155/2014/718732. Epub 2014 Apr 3. Biomed Res Int. 2014. PMID: 24804238 Free PMC article.

8

miRNA expression is highly sensitive to a drug therapy in Parkinson's disease.

Alieva AKh, Filatova EV, Karabanov AV, Illarioshkin SN, Limborska SA, Shadrina MI, Slominsky PA. Alieva AKh, et al. Among authors: slominsky pa. Parkinsonism Relat Disord. 2015 Jan;21(1):72-4. doi: 10.1016/j.parkreldis.2014.10.018. Epub 2014 Oct 27. Parkinsonism Relat Disord. 2015. PMID: 25465742

9

Selank Administration Affects the Expression of Some Genes Involved in GABAergic Neurotransmission.

Volkova A, Shadrina M, Kolomin T, Andreeva L, Limborska S, Myasoedov N, Slominsky P. Volkova A, et al. Front Pharmacol. 2016 Feb 18;7:31. doi: 10.3389/fphar.2016.00031. eCollection 2016. Front Pharmacol. 2016. PMID: 26924987 Free PMC article.

10

Transcriptome Profile Changes in Mice with MPTP-Induced Early Stages of Parkinson's Disease.

Alieva AK, Filatova EV, Kolacheva AA, Rudenok MM, Slominsky PA, Ugrumov MV, Shadrina MI. Alieva AK, et al. Among authors: slominsky pa. Mol Neurobiol. 2017 Nov;54(9):6775-6784. doi: 10.1007/s12035-016-0190-y. Epub 2016 Oct 18. Mol Neurobiol. 2017. PMID: 27757834

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

96 results

Search Page

Filters